229 related articles for article (PubMed ID: 23322687)
41. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor κB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading.
Plotkin LI; Gortazar AR; Davis HM; Condon KW; Gabilondo H; Maycas M; Allen MR; Bellido T
J Biol Chem; 2015 Jul; 290(31):18934-42. PubMed ID: 26085098
[TBL] [Abstract][Full Text] [Related]
43. MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice.
Kim HN; Lee JH; Jin WJ; Ko S; Jung K; Ha H; Lee ZH
Eur J Pharmacol; 2012 Sep; 691(1-3):69-76. PubMed ID: 22846626
[TBL] [Abstract][Full Text] [Related]
44. Deficiency of CIZ, a nucleocytoplasmic shuttling protein, prevents unloading-induced bone loss through the enhancement of osteoblastic bone formation in vivo.
Hino K; Nakamoto T; Nifuji A; Morinobu M; Yamamoto H; Ezura Y; Noda M
Bone; 2007 Apr; 40(4):852-60. PubMed ID: 17301008
[TBL] [Abstract][Full Text] [Related]
45. Geranylgeranylacetone inhibits formation and function of human osteoclasts and prevents bone loss in tail-suspended rats and ovariectomized rats.
Nanke Y; Kotake S; Ninomiya T; Furuya T; Ozawa H; Kamatani N
Calcif Tissue Int; 2005 Dec; 77(6):376-85. PubMed ID: 16362462
[TBL] [Abstract][Full Text] [Related]
46. The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival.
Ochi H; Hara Y; Tagawa M; Shinomiya K; Asou Y
J Orthop Res; 2010 May; 28(5):657-63. PubMed ID: 19890995
[TBL] [Abstract][Full Text] [Related]
47. Periostin expression contributes to cortical bone loss during unloading.
Gerbaix M; Vico L; Ferrari SL; Bonnet N
Bone; 2015 Feb; 71():94-100. PubMed ID: 25445447
[TBL] [Abstract][Full Text] [Related]
48. The impact of skeletal unloading on bone formation.
Bikle DD; Sakata T; Halloran BP
Gravit Space Biol Bull; 2003 Jun; 16(2):45-54. PubMed ID: 12959131
[TBL] [Abstract][Full Text] [Related]
49. Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.
Sugatani T
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142896
[TBL] [Abstract][Full Text] [Related]
50. MAGED1 is a negative regulator of bone remodeling in mice.
Liu M; Xu L; Ma X; Xu J; Wang J; Xian M; Zhou X; Wang M; Wang F; Qin A; Pan Q; Wen C
Am J Pathol; 2015 Oct; 185(10):2653-67. PubMed ID: 26272363
[TBL] [Abstract][Full Text] [Related]
51. Mitochondrial dysfunction impairs osteogenesis, increases osteoclast activity, and accelerates age related bone loss.
Dobson PF; Dennis EP; Hipps D; Reeve A; Laude A; Bradshaw C; Stamp C; Smith A; Deehan DJ; Turnbull DM; Greaves LC
Sci Rep; 2020 Jul; 10(1):11643. PubMed ID: 32669663
[TBL] [Abstract][Full Text] [Related]
52. Accentuated ovariectomy-induced bone loss and altered osteogenesis in heterozygous N-cadherin null mice.
Lai CF; Cheng SL; Mbalaviele G; Donsante C; Watkins M; Radice GL; Civitelli R
J Bone Miner Res; 2006 Dec; 21(12):1897-906. PubMed ID: 17002573
[TBL] [Abstract][Full Text] [Related]
53. Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.
Wang L; Liu S; Zhao Y; Liu D; Liu Y; Chen C; Karray S; Shi S; Jin Y
Cell Death Differ; 2015 Oct; 22(10):1654-64. PubMed ID: 25744024
[TBL] [Abstract][Full Text] [Related]
54. Blocking glucocorticoid signaling in osteoblasts and osteocytes prevents mechanical unloading-induced cortical bone loss.
Yang J; Li J; Cui X; Li W; Xue Y; Shang P; Zhang H
Bone; 2020 Jan; 130():115108. PubMed ID: 31704341
[TBL] [Abstract][Full Text] [Related]
55. The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders.
Saponaro F; Ferrisi R; Gado F; Polini B; Saba A; Manera C; Chiellini G
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830256
[TBL] [Abstract][Full Text] [Related]
56. The Role of NF-κB in Physiological Bone Development and Inflammatory Bone Diseases: Is NF-κB Inhibition "Killing Two Birds with One Stone"?
Jimi E; Takakura N; Hiura F; Nakamura I; Hirata-Tsuchiya S
Cells; 2019 Dec; 8(12):. PubMed ID: 31847314
[TBL] [Abstract][Full Text] [Related]
57. DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age.
Kim HN; Chang J; Shao L; Han L; Iyer S; Manolagas SC; O'Brien CA; Jilka RL; Zhou D; Almeida M
Aging Cell; 2017 Aug; 16(4):693-703. PubMed ID: 28401730
[TBL] [Abstract][Full Text] [Related]
58. Short-term effects of whole-body exposure to (56)fe ions in combination with musculoskeletal disuse on bone cells.
Yumoto K; Globus RK; Mojarrab R; Arakaki J; Wang A; Searby ND; Almeida EA; Limoli CL
Radiat Res; 2010 Apr; 173(4):494-504. PubMed ID: 20334522
[TBL] [Abstract][Full Text] [Related]
59. Mitochondrial superoxide in osteocytes perturbs canalicular networks in the setting of age-related osteoporosis.
Kobayashi K; Nojiri H; Saita Y; Morikawa D; Ozawa Y; Watanabe K; Koike M; Asou Y; Shirasawa T; Yokote K; Kaneko K; Shimizu T
Sci Rep; 2015 Mar; 5():9148. PubMed ID: 25779629
[TBL] [Abstract][Full Text] [Related]
60. Connexin 43 deficiency attenuates loss of trabecular bone and prevents suppression of cortical bone formation during unloading.
Lloyd SA; Lewis GS; Zhang Y; Paul EM; Donahue HJ
J Bone Miner Res; 2012 Nov; 27(11):2359-72. PubMed ID: 22714552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
